Related Experiment Videos
Tau in Alzheimer's disease
1Max-Planck-Unit for Structural Molecular Biology, Hamburg, Germany. mand@mpasmb.desy.de
Trends in Cell Biology
|December 17, 1998
Summary
Abnormal tau protein tangles are key in Alzheimer's disease (AD). Research suggests tau pathology, not beta-amyloid, may be a more reliable indicator of AD progression and neuronal death.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Tau protein stabilizes microtubules in healthy neurons, essential for intracellular transport.
- In Alzheimer's disease (AD), tau protein undergoes abnormal phosphorylation, forming aggregates and destabilizing microtubules.
- Recent discoveries of tau gene mutations have refocused attention on tau's role in neurodegeneration.
Purpose of the Study:
- To explore how alterations in tau protein contribute to neuronal process retraction and cell death.
- To evaluate tau pathology as a potential primary indicator for Alzheimer's disease.
Main Methods:
- Review of existing literature on tau protein function and dysfunction in Alzheimer's disease.
- Analysis of the relationship between tau pathology and neurodegenerative mechanisms.
- Comparison of the indicative value of tau pathology versus beta-amyloid in AD.
Main Results:
- Abnormal tau phosphorylation and aggregation disrupt microtubule stability.
- Altered tau function can lead to the retraction of neuronal processes, resulting in cell death.
- Tau pathology shows potential as a more reliable biomarker for AD than beta-amyloid.
Conclusions:
- Tau protein's role in microtubule stabilization is critical for neuronal health.
- Dysfunctional tau is strongly implicated in the pathogenesis of Alzheimer's disease.
- Tau pathology may serve as a more dependable diagnostic and prognostic marker for AD.